Yogish C. Kudva
NIH Rank #26008
- R01 Award PI
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7873228Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$318.4K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#26,008
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Yogish C. Kudva as a PI. Multi-PI records show the full award amount for context.
- 5R01DK137868-03R01Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial$318.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing Yogish C. Kudva as a PI.
FY2026 award administered by Mayo Clinic (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2025$500K Cumulative Linked Award Amount
- 2025$1M Cumulative Linked Award Amount
- 2025$2M Cumulative Linked Award Amount
- 2025Reached Top 50% by Award-Linked RankRanked #2661
- 2025Reached Top 25% by Award-Linked RankRanked #2661
- 2025R01 Award Record
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Yogish C. Kudva.